Methylin Chewable Tablets Return To Market For ADHD
This article was originally published in The Pink Sheet Daily
Executive Summary
Alliant Pharmaceuticals has returned the only chewable tablet for the treatment of attention deficit/hyperactivity disorder in children to the market. The company announced the availability of Methylin (methylphenidate) tablets June 6